These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2796376

  • 1. Hemoglobin induction by Ara-C in human erythroleukemic cells (K562) is cell-cycle dependent.
    Wanda PE, Walker MM.
    Leuk Res; 1989; 13(8):683-8. PubMed ID: 2796376
    [Abstract] [Full Text] [Related]

  • 2. Induction to erythroid differentiation of K562 cells by 1-beta-D-arabinofuranosylcytosine is inhibited by iron chelators: reversion by treatment with hemin.
    Feriotto G, Nastruzzi C, Barbieri R, Gambari R.
    Blut; 1988 Jul; 57(1):25-30. PubMed ID: 3164639
    [Abstract] [Full Text] [Related]

  • 3. Induction of terminal differentiation in human K562 erythroleukemia cells by arabinofuranosylcytosine.
    Luisi-DeLuca C, Mitchell T, Spriggs D, Kufe DW.
    J Clin Invest; 1984 Sep; 74(3):821-7. PubMed ID: 6590568
    [Abstract] [Full Text] [Related]

  • 4. Induction of differentiation in erythroleukemic K562 cells by gamma-irradiation.
    Schwenke K, Peterson HP, Wangenheim KH, Feinendegen LE.
    Leuk Res; 1995 Dec; 19(12):955-61. PubMed ID: 8632665
    [Abstract] [Full Text] [Related]

  • 5. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
    Okabe-Kado J, Hayashi M, Honma Y, Hozumi M.
    Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
    [Abstract] [Full Text] [Related]

  • 6. In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation.
    Toffoli G, Viel A, Bevilacqua C, Maestro R, Tumiotto L, Boiocchi M.
    Leuk Res; 1989 Mar; 13(4):279-87. PubMed ID: 2654492
    [Abstract] [Full Text] [Related]

  • 7. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL, Wu RT.
    Cancer Res; 1994 Apr 15; 54(8):2192-8. PubMed ID: 7513611
    [Abstract] [Full Text] [Related]

  • 8. Immunochemical detection of cell cycle synchronization in a human erythroleukemia cell line, K562.
    Walker MM, Wanda PE.
    J Histochem Cytochem; 1987 Oct 15; 35(10):1143-8. PubMed ID: 3476671
    [Abstract] [Full Text] [Related]

  • 9. ETS-1 induces increased expression of erythroid markers in the pluripotent erythroleukemic cell lines K562 and HEL.
    Clausen PA, Athanasiou M, Chen Z, Dunn KJ, Zhang Q, Lautenberger JA, Mavrothalassitis G, Blair DG.
    Leukemia; 1997 Aug 15; 11(8):1224-33. PubMed ID: 9264374
    [Abstract] [Full Text] [Related]

  • 10. Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cells.
    Baker SJ, Pawlita M, Leutz A, Hoelzer D.
    Leukemia; 1994 Aug 15; 8(8):1309-17. PubMed ID: 8057666
    [Abstract] [Full Text] [Related]

  • 11. Differential hemoglobin synthesis in murine erythroleukemic cells: hemin effects.
    Zucker RM, Umlas ME, Decal DL, Whittington KB.
    Cell Biochem Funct; 1987 Jan 15; 5(1):27-35. PubMed ID: 3469035
    [Abstract] [Full Text] [Related]

  • 12. Glycolytic enzymes of an erythroleukemic cell line, K562, before and after hemoglobin induction.
    Jansen G, Rijksen G, de Gast GC, Staal GE.
    Exp Hematol; 1983 Aug 15; 11(7):626-38. PubMed ID: 6224699
    [Abstract] [Full Text] [Related]

  • 13. Hemin uptake by erythroleukemic cells treated with iron chelators: effects on the induced expression of differentiated functions.
    Feriotto G, Nastruzzi C, Traniello F, Barbieri R, Gambari R.
    Boll Soc Ital Biol Sper; 1987 Oct 31; 63(10):869-73. PubMed ID: 3482157
    [No Abstract] [Full Text] [Related]

  • 14. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
    Watanabe T, Mitchell T, Sariban E, Sabbath K, Griffin J, Kufe D.
    Mol Pharmacol; 1985 Jun 31; 27(6):683-8. PubMed ID: 3858662
    [Abstract] [Full Text] [Related]

  • 15. Effects of hyperthermia on the differentiation and growth of K562 erythroleukemic cell line.
    Goliaei B, Rafiei M, Soheili Z.
    Leuk Res; 2004 Dec 31; 28(12):1323-8. PubMed ID: 15475074
    [Abstract] [Full Text] [Related]

  • 16. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
    Honma Y, Onozuka Y, Okabe-Kado J, Kasukabe T, Hozumi M.
    Cancer Res; 1991 Sep 01; 51(17):4535-8. PubMed ID: 1873797
    [Abstract] [Full Text] [Related]

  • 17. Inhibition by 1,25 dihydroxyvitamin D3 of c-myc down-regulation and DNA fragmentation in cytosine arabinoside-induced erythroid differentiation of K562 cells.
    Moore DC, Carter DL, Studzinski GP.
    J Cell Physiol; 1992 Jun 01; 151(3):539-48. PubMed ID: 1295901
    [Abstract] [Full Text] [Related]

  • 18. Activin A-induced differentiation in K562 cells is associated with a transient hypophosphorylation of RB protein and the concomitant block of cell cycle at G1 phase.
    Sehy DW, Shao LE, Yu AL, Tsai WM, Yu J.
    J Cell Biochem; 1992 Nov 01; 50(3):255-65. PubMed ID: 1361489
    [Abstract] [Full Text] [Related]

  • 19. Cellular and clinical pharmacology of low-dose ara-C.
    Kufe DW, Griffin JD, Spriggs DR.
    Semin Oncol; 1985 Jun 01; 12(2 Suppl 3):200-7. PubMed ID: 3925558
    [Abstract] [Full Text] [Related]

  • 20. Protease induction of hemoglobin synthesis but not terminal cell division in K562 cells.
    Scher W, Hellinger N, Waxman S.
    Exp Hematol; 1985 Jan 01; 13(1):36-43. PubMed ID: 3882441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.